vs
Side-by-side financial comparison of HANMI FINANCIAL CORP (HAFC) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.
PUMA BIOTECHNOLOGY, INC. is the larger business by last-quarter revenue ($75.5M vs $71.2M, roughly 1.1× HANMI FINANCIAL CORP). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs 17.1%). HANMI FINANCIAL CORP produced more free cash flow last quarter ($203.7M vs $14.4M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 10.4%).
Hanmi Bank Corporation is a community bank headquartered in Los Angeles, California, with 35 branches and eight loan production offices in California, Texas, Illinois, New York, New Jersey and Virginia.
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
HAFC vs PBYI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $71.2M | $75.5M |
| Net Profit | $21.2M | — |
| Gross Margin | — | 69.3% |
| Operating Margin | 29.8% | 22.7% |
| Net Margin | 29.8% | — |
| Revenue YoY | 17.1% | 27.7% |
| Net Profit YoY | 20.0% | — |
| EPS (diluted) | $0.70 | $0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $71.2M | $75.5M | ||
| Q3 25 | $71.0M | $54.5M | ||
| Q2 25 | $65.2M | $52.4M | ||
| Q1 25 | $62.8M | $46.0M | ||
| Q4 24 | $60.8M | $59.1M | ||
| Q3 24 | $58.5M | $80.5M | ||
| Q2 24 | $56.7M | $47.1M | ||
| Q1 24 | $58.4M | $43.8M |
| Q4 25 | $21.2M | — | ||
| Q3 25 | $22.1M | $8.8M | ||
| Q2 25 | $15.1M | $5.9M | ||
| Q1 25 | $17.7M | $3.0M | ||
| Q4 24 | $17.7M | — | ||
| Q3 24 | $14.9M | $20.3M | ||
| Q2 24 | $14.5M | $-4.5M | ||
| Q1 24 | $15.2M | $-4.8M |
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
| Q4 25 | 29.8% | 22.7% | ||
| Q3 25 | 31.1% | 17.6% | ||
| Q2 25 | 23.2% | 12.7% | ||
| Q1 25 | 28.1% | 8.7% | ||
| Q4 24 | 29.1% | 22.6% | ||
| Q3 24 | 25.5% | 27.4% | ||
| Q2 24 | 25.5% | -4.6% | ||
| Q1 24 | 26.0% | -5.3% |
| Q4 25 | 29.8% | — | ||
| Q3 25 | 31.1% | 16.2% | ||
| Q2 25 | 23.2% | 11.2% | ||
| Q1 25 | 28.1% | 6.5% | ||
| Q4 24 | 29.1% | — | ||
| Q3 24 | 25.5% | 25.2% | ||
| Q2 24 | 25.5% | -9.6% | ||
| Q1 24 | 26.0% | -11.0% |
| Q4 25 | $0.70 | $0.26 | ||
| Q3 25 | $0.73 | $0.17 | ||
| Q2 25 | $0.50 | $0.12 | ||
| Q1 25 | $0.58 | $0.06 | ||
| Q4 24 | $0.58 | $0.40 | ||
| Q3 24 | $0.49 | $0.41 | ||
| Q2 24 | $0.48 | $-0.09 | ||
| Q1 24 | $0.50 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $97.5M |
| Total DebtLower is stronger | — | $22.7M |
| Stockholders' EquityBook value | $796.4M | $130.3M |
| Total Assets | $7.9B | $216.3M |
| Debt / EquityLower = less leverage | — | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $97.5M | ||
| Q3 25 | — | $94.4M | ||
| Q2 25 | — | $96.0M | ||
| Q1 25 | — | $93.2M | ||
| Q4 24 | — | $101.0M | ||
| Q3 24 | — | $96.7M | ||
| Q2 24 | — | $96.8M | ||
| Q1 24 | — | $107.2M |
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
| Q4 25 | $796.4M | $130.3M | ||
| Q3 25 | $779.5M | $115.3M | ||
| Q2 25 | $762.8M | $104.7M | ||
| Q1 25 | $751.5M | $97.1M | ||
| Q4 24 | $732.2M | $92.1M | ||
| Q3 24 | $736.7M | $71.1M | ||
| Q2 24 | $707.1M | $48.5M | ||
| Q1 24 | $703.1M | $51.0M |
| Q4 25 | $7.9B | $216.3M | ||
| Q3 25 | $7.9B | $202.9M | ||
| Q2 25 | $7.9B | $194.9M | ||
| Q1 25 | $7.7B | $196.2M | ||
| Q4 24 | $7.7B | $213.3M | ||
| Q3 24 | $7.7B | $220.7M | ||
| Q2 24 | $7.6B | $205.0M | ||
| Q1 24 | $7.5B | $214.1M |
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $206.0M | $14.4M |
| Free Cash FlowOCF − Capex | $203.7M | $14.4M |
| FCF MarginFCF / Revenue | 286.2% | 19.1% |
| Capex IntensityCapex / Revenue | 3.2% | 0.0% |
| Cash ConversionOCF / Net Profit | 9.70× | — |
| TTM Free Cash FlowTrailing 4 quarters | $356.1M | $41.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $206.0M | $14.4M | ||
| Q3 25 | $146.9M | $9.7M | ||
| Q2 25 | $-19.0M | $14.1M | ||
| Q1 25 | $25.8M | $3.6M | ||
| Q4 24 | $52.6M | $15.6M | ||
| Q3 24 | $6.7M | $11.0M | ||
| Q2 24 | $2.1M | $1.0M | ||
| Q1 24 | $30.0M | $11.2M |
| Q4 25 | $203.7M | $14.4M | ||
| Q3 25 | $146.4M | $9.7M | ||
| Q2 25 | $-19.6M | $14.1M | ||
| Q1 25 | $25.6M | $3.6M | ||
| Q4 24 | $49.9M | $15.6M | ||
| Q3 24 | $6.5M | $11.0M | ||
| Q2 24 | $1.3M | $1.0M | ||
| Q1 24 | $29.2M | — |
| Q4 25 | 286.2% | 19.1% | ||
| Q3 25 | 206.3% | 17.7% | ||
| Q2 25 | -30.0% | 26.8% | ||
| Q1 25 | 40.7% | 7.7% | ||
| Q4 24 | 82.1% | 26.4% | ||
| Q3 24 | 11.1% | 13.7% | ||
| Q2 24 | 2.3% | 2.1% | ||
| Q1 24 | 50.0% | — |
| Q4 25 | 3.2% | 0.0% | ||
| Q3 25 | 0.8% | 0.0% | ||
| Q2 25 | 0.9% | 0.0% | ||
| Q1 25 | 0.4% | 0.1% | ||
| Q4 24 | 4.3% | 0.0% | ||
| Q3 24 | 0.4% | 0.0% | ||
| Q2 24 | 1.4% | 0.0% | ||
| Q1 24 | 1.4% | 0.0% |
| Q4 25 | 9.70× | — | ||
| Q3 25 | 6.66× | 1.10× | ||
| Q2 25 | -1.26× | 2.41× | ||
| Q1 25 | 1.46× | 1.21× | ||
| Q4 24 | 2.97× | — | ||
| Q3 24 | 0.45× | 0.54× | ||
| Q2 24 | 0.14× | — | ||
| Q1 24 | 1.98× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
